Real-world treatment outcomes with halobetasol propionate 0.01%/tazarotene 0.045% lotion in patients with mild-to-moderate plaque psoriasis: A Canadian multicenter retrospective chart review

Ronald Vender; Irina Turchin; Perla Lansang; Vimal H Prajapati; Mark Legault; Maxime Barakat; Jensen Yeung

doi:10.1016/j.jdin.2022.05.001

Real-world treatment outcomes with halobetasol propionate 0.01%/tazarotene 0.045% lotion in patients with mild-to-moderate plaque psoriasis: A Canadian multicenter retrospective chart review

JAAD Int. 2022 Jun 13:8:60-63. doi: 10.1016/j.jdin.2022.05.001. eCollection 2022 Sep.

Authors

Ronald Vender^{1

2}, Irina Turchin^{3

4

5}, Perla Lansang^{6

7

8

9}, Vimal H Prajapati^{10

11

12

13

14

15}, Mark Legault¹⁶, Maxime Barakat¹⁶, Jensen Yeung^{6

7}

Affiliations

¹ Department of Medicine, Division of Dermatology, McMaster University, Hamilton, Ontario, Canada.
² Dermatrials Research Inc, Hamilton, Ontario, Canada.
³ Brunswick Dermatology Centre, Fredericton, New Brunswick, Canada.
⁴ Dalhousie University, Halifax, Nova Scotia, Canada.
⁵ Probity Medical Research, Waterloo, Ontario, Canada.
⁶ Division of Dermatology, Women's College Hospital, Toronto, Ontario, Canada.
⁷ Division of Dermatology, Faculty of Medicine, University of Toronto, Toronto, Ontario, Canada.
⁸ Division of Dermatology, Department of Medicine, Sunnybrook Health Sciences Centre, University of Toronto, Toronto, Ontario, Canada.
⁹ The Hospital for Sick Children, Toronto, Ontario, Canada.
¹⁰ Division of Dermatology, Department of Medicine, University of Calgary, Calgary, Alberta, Canada.
¹¹ Section of Community Pediatrics, Department of Pediatrics, University of Calgary, Calgary, Alberta, Canada.
¹² Section of Pediatric Rheumatology, Department of Pediatrics, University of Calgary, Calgary, Alberta, Canada.
¹³ Dermatology Research Institute, Calgary, Alberta, Canada.
¹⁴ Skin Health & Wellness Centre, Calgary, Alberta, Canada.
¹⁵ Probity Medical Research, Calgary, Alberta, Canada.
¹⁶ Bausch Health Canada Inc, Laval, Quebec, Canada.

No abstract available

Keywords: biologic; corticosteroid; fixed combination; plaque psoriasis; real-world; retinoid; retrospective chart review; topical.